Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Fallahi, B. [1 ]
Beiki, D. [1 ]
Takavar, A. [1 ]
Eftekhari, M. [1 ]
Fard-Esfahani, A. [1 ]
Gilani, K. Ansari [1 ]
Saghari, M. [1 ]
机构：
[1] Univ Tehran Med Sci, Res Inst Nucl Med, Tehran, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [1] Thyroid remnant I-131 ablation for papillary and follicular thyroid carcinoma
    Mazzaferri, EL
    THYROID, 1997, 7 (02) : 265 - 271
  • [2] FACTORS AFFECTING I-131 ABLATION OF THYROID REMNANT AFTER THYROIDECTOMY FOR DIFFERENTIATED THYROID-CANCER
    CECCARELLI, C
    MARTINO, E
    LIPPI, F
    GIANCHECCHI, D
    LUCHETTI, F
    BRACCI, E
    PINCHERA, A
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 46 - 46
  • [3] Thyroid remnant ablation of differentiated thyroid carcinoma: a comparison of ablation success with high and low doses of radioiodine (I-131)
    Elrasad, S. A. A.
    Abdelhafeez, Y.
    Husseini, M. A.
    Amin, R. A. A.
    Elrefaei, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S328 - S328
  • [4] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Prpic, Marin
    Dabelic, Nina
    Stanicic, Josip
    Jukic, Tomislav
    Milosevic, Milan
    Kusic, Zvonko
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (09) : 744 - 751
  • [5] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Marin Prpic
    Nina Dabelic
    Josip Stanicic
    Tomislav Jukic
    Milan Milosevic
    Zvonko Kusic
    Annals of Nuclear Medicine, 2012, 26 : 744 - 751
  • [6] Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma
    Taube, A
    Lundell, G
    CANCER, 1997, 79 (01) : 190 - 190
  • [7] Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma
    Bal, C
    Padhy, AK
    Jana, S
    Pant, GS
    Basu, AK
    CANCER, 1996, 77 (12) : 2574 - 2580
  • [8] rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity
    Ambrosetti, M. C.
    Francia, G.
    Davi, M. V.
    Brazzarola, P.
    Rossi, L.
    Colato, C.
    Dardano, A.
    Monzani, F.
    Mucelli, R. Pozzi
    Lo Cascio, V.
    Ferdeghini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S140 - S140
  • [9] Low versus High I-131 Dose for Remnant Ablation in Differentiated Thyroid Cancer
    Hackshaw, Allan
    Mallick, Ujjal
    CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) : 1 - 1
  • [10] Low-risk differentiated thyroid carcinoma patients still deserve I-131 remnant ablation after total thyroidectomy
    Verburg, F. A.
    Luster, M.
    MINERVA CHIRURGICA, 2010, 65 (01) : 95 - 100
12345